Effects of lipoprotein(a) on mesangial cell proliferation and viability

Nephrology Dialysis Transplantation

Volumn 11, Issue 5, 1996, Pages 778-785

  Greiber, S ^a   Kramer Guth A ^a   Pavenstadt H ^a   Gutenkunst, M ^a   Schollmeyer, P ^a   Wanner, C ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Immediate early response genes; Lipoprotein(a); Oxygen radicals; Proliferation; Rat mesangial cells

Indexed keywords

CATALASE; LIPOPROTEIN A; MESSENGER RNA; OXYGEN RADICAL; SUPEROXIDE DISMUTASE; TRITIUM;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; FETAL CALF SERUM; IMMEDIATE EARLY GENE; LIPOPROTEIN BLOOD LEVEL; MESANGIUM CELL; NEPHROTIC SYNDROME; NONHUMAN; ONCOGENE C FOS; ONCOGENE C MYC; PRIORITY JOURNAL; RAT;

EID: 0029872373     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027398     Document Type: Article

References (48)

1. Keane WF, Kasiske BL, O'Donnell MP. Hyperlipidemia and the progression of renal disease. Am J Clin Nutr 1988: 47: 157-160
2. Diamond JR. Analogous pathobiological mechanisms in glomerulosclerosis and atherosclerosis. Kidney Int 1991; 39 [Suppl 31]: S29-S34
3. Schlondorif D. The glomerular mesangial cell: an expanding role for a specialized pericyte. FASEB J 1987: 1: 272-281
4. Utermann G. The mysteries of lipoprotein (a). Science 1989; 246: 904-910
5. Scanu AM. Fless GM. Lipoprotein (a). Heterogeneity and biological relevance. J Clin Invest 1990; 85: 1709-1715
6. Gaubatz JW, Ghanem Kl, Guevara JJ, Nava ML, Patsch W, Morrisett JD. Polymorphic forms of human apolipoprotein[a]: inheritance and relationship of their molecular weights to plasma levels of lipoprotein (a). J Lipid Res 1990: 31: 603-613
7. Klausen IC, Beisiegel U, Menzel HJ et al.. Apo(a) phenotypes and Lp(a) concentrations in offspring of men with and without myocardial infarction. The EARS Study. European Atherosclerosis Research Study. Artertoscler Thromb Biol 1995; 15: 1001-1008
8. Grainger DJ, Kirschenlohr HL, Metcalfe JC, Weissberg PL, Wade DP, Lawn RM. Proliferation of human smooth muscle cells promoted by lipoprotein (a). Science 1993; 260: 1655-1658
9. Sato H. Suzuki S, Ueno M et al. Localization of apolipoprotein(a) and B-100 in various renal diseases. Kidney Int 1993; 43: 430-435
10. Wasserman J, Santiago A, Rifici V et al. Interactions of lowdensity lipoprotein with rat mesangial cells. Kidney Int 1989; 35: 1168-1174
11. Wheeler DC, Persaud JW, Fernando R, Sweny P, Varghese Z, Moorhead JF. Effects of low-density lipoproteins on mesangial cell arowth and viability in vitro. Nephrol Dial Transplant 1990: 5: 185-191
12. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993; 362: 801-809
13. Shah SV. Role of oxygen reactive metabolites in experimental glomerular disease. Kidney Int 1989; 35. 1093-1106
14. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia induces endothelial superoxide anion production. J Clin Invest 1993; 91: 2546-2551
15. Rovin BH. Tan L. DL stimulates mesangial fibronectin production and chemoattractant expression. Kidney Int 1993; 43: 218-225
16. Hansen PR, Kharazami A, Jauhiamen M, Ehnholm C. Induction of oxygen free radical generation in human monocytes by lipoprotein (a), Eur J Clin Invest 1994; 24: 497-499
17. Pfeilschifter J, Kurtz A, Bauer C. Role of phospholipase C and protein kinase C in vasoconstrictor-induced prostaglandin synthesis in cultured rat renal mesangial cells. Biochem J 1986; 234: 125-130
18. Mitchmson MJ, Ball RY. Macrophages and atherogenesis. Lancet 1987; 2: 146-148
19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurements with the folin phenol reagent. J Biol Chem 1951; 193: 265-270
20. Wanner C, Rader D, Bartens W et al Elevated plasma lipoprotein(a) in patients with the nephrotic syndrom. Ann Intern Med 1993; 119: 263-269
21. Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest 1987: 80: 458-465
22. Cooper JF, Levin J, Wagner HN. Quantitative comparison of in vitro and in vivo methods for the detection of endotoxin J Lab Clin Med 1971: 78: 138-148
23. Van Gelder BF, Slater EC. The extinction coefficient of cytochrome c. Biochim Btophys Acta 1962; 58: 593-595
24. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159
25. Sambrook J, Fritsch EF, Manitias T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, New York, 1989
26. Land H, Parada LF, Weinberg RA. Tumorigenic conversion of primary embryo fibroblasts. Nature 1983; 304: 596-602
27. Miller AD, Curran T, Verma IM. C-fos protein can induce cellular transformation. Cell 1984; 36: 51-60
28. Fogo A, Hawkins EP, Berry PL et al. Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular Sclerosis. Kidney Int 1990: 38: 115-123
29. Eng E, Floege J, Young BA. Couser WG, Johnson RJ. Does extracellular matrix expansion in glomerular disease require mesangial proliferation? Kidney lnt 1994; 45[Suppl 45]: S45-S47
30. Gröne EF, Abboud HE, Höhne M et al. Actions of lipoproteins in cultured human mesangial cells: modulation by mitogenic vasoconstrictors. Am J Physiol 1992; 263: F686-F696
31. Ding G, Pesek-Diamond I. Diamond JR. Cholesterol, macrophages and gene expression of TGF-beta and fibronectin during nephrosis. Am J Physiol 1993; 254: F577-F584
32. Floege J, Eng E, Young B, Johnson RJ. Factors involved in the regulation of mesanaial cell proliferation in vitro and in vivo. Kidney Int 1993; [Suppl. 39]: 47-54
33. Lau LF, Nathans D. Expression of a set of growth-related immediate early genes in BALB c 3T3 cells: coordinate regulation with c-fos or c-myc. Proc Natl Acad Sci USA 1987; 84: 1182-1186
34. Sassone-Corsi P, Lamph WW, Kamps M. Verma IM. Fosassociated cellular p39 is related to nuclear transcription factor AP-1. Cell 1988; 54: 553-560
35. Marcu KB. Bossone SA, Patel AJ. myc function and regulation. (Review). Annu Rey Biochem 1992; 61: 809-860
36. Karin M. The Ap-1 complex and its role in the transcriptional role of protein kinase C. In: Cohen P, Foulkes JG, eds. The Hormonal Control Regulation of Gene Transcription, 1991
37. Kreisberg JI, Radnike RA, Ayo SH, Garoni J, Saikumar P, High glucose elevates c-fos and c-jun transcripts and protein in mesangial cell cultures. Kidney Int 1994; 46: 105-112
38. Schonthal A, Herrlich P, Rahmsdorf HJ, Ponta H. Requirements for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esthers. Cell 1988; 54: 325-334
39. Scott-Burden T, Resink TJ, Hahn AW, Baur U, Box RJ. Bühler FR. Induction of growth-related metabolism in human vascular smooth muscle cells by low density lipoprotein. J Biol Chem 1989; 264: 12582-12589
40. Maki A, Berezesky IK, Fargnoli J, Holbrook NJ, Trump BF. Role of [Ca2+]i in induction of c-fos. c-jun. and c-myc mRNA in rat PTE after oxidative stress. FASEB J 1992: 6: 919-924
41. Schreck R. Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 1991; 10: 2247-2258
42. Toledano MB. Leonard WJ. Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro, Proc Natl A cad Sci USA 1991: 88: 4328-4332
43. Abate C, Patel L, Rauscher FJ, Curran T. Redox regulation of fos and jun DNA-binding activity in vitro. Science 1990; 249: 1157-1161
44. Johnson RJ, Lovett D, Lehrer RI, Couser WG, Klebanoff SJ. Role of oxidants and protease in glomerular injury. Kidney Int 1994; 45: 352-359
45. Galle J, Stunz P, Schollmeyer P, Wanner C. Oxidized LDL and Lipoprotein (a) stimulate renin secretion of juxtaglomerular cells. Kidney Int 1995: 47: 45-50
46. Ichikawa I, Kiyama S, Yoshioka T. Renal antioxidant enzymes: their regulation and function. Kidney Int 1994; 45: 1-9
47. Wheeler DC, Ravinder SC. Topley N, Petersen MM, Davies M, Williams JD. Oxidation of low density lipoprotein by mesangial cells may promote slomerular injury. Kidney Int 1994; 45: 1628-1636
48. Kosugi K, Morel DW. DiCorleto PE, Chisolm GM. Toxicity of oxidized low-density lipoprotein to cultured fibroblasts is selective for S phase of the cell culture cycle. J Cell Physiol 1987; 130: 311-320